open access

Vol 10, No 2 (2013)
Review paper
Get Citation

Standardized, interactive tests to diagnose autism spectrum disorder (ASD) and new diagnostic criteria in DSM-5

Agnieszka Rynkiewicz, Marta Kulik
Psychiatria 2013;10(2):41-48.

open access

Vol 10, No 2 (2013)
Prace poglądowe - nadesłane

Abstract

In May 2013, the American Psychiatric Association, APA released the Diagnostic and Statistical Manual of Mental Disorders, the fifth edition, DSM-5. The big changes to the new criteria of ASD in DSM-5 have been implemented. Also the standardized, interactive tests from the diagnostic “gold standard” have been revised. In DSM-5 all previously existing diagnosis of DSM-IV under Pervasive Developmental Disorders were merged into one diagnosis called Autism Spectrum Disorder, ASD. The term “spectrum” reflects both the differences within the ASD group itself in regards to the symptoms but also reflects continuum between general population and ASD group. DSM-IV and DSM-5 criteria were compared in research according to their sensitivity and specificity. The results of the study showed higher specificity of DSM-5 criteria which means less false positive diagnoses. However some of the patients who received ASD diagnosis based on DSM-IV criteria do not meet the current criteria of DSM-5. Due to the recent big changes to ASD criteria and also within the standardized, interactive diagnostic tests for ASD it seems important to provide and publish reliable facts and knowledge on it to the professionals, especially in the countries, Poland included, where these tests are being currently introduced.

Abstract

In May 2013, the American Psychiatric Association, APA released the Diagnostic and Statistical Manual of Mental Disorders, the fifth edition, DSM-5. The big changes to the new criteria of ASD in DSM-5 have been implemented. Also the standardized, interactive tests from the diagnostic “gold standard” have been revised. In DSM-5 all previously existing diagnosis of DSM-IV under Pervasive Developmental Disorders were merged into one diagnosis called Autism Spectrum Disorder, ASD. The term “spectrum” reflects both the differences within the ASD group itself in regards to the symptoms but also reflects continuum between general population and ASD group. DSM-IV and DSM-5 criteria were compared in research according to their sensitivity and specificity. The results of the study showed higher specificity of DSM-5 criteria which means less false positive diagnoses. However some of the patients who received ASD diagnosis based on DSM-IV criteria do not meet the current criteria of DSM-5. Due to the recent big changes to ASD criteria and also within the standardized, interactive diagnostic tests for ASD it seems important to provide and publish reliable facts and knowledge on it to the professionals, especially in the countries, Poland included, where these tests are being currently introduced.

Get Citation

Keywords

autism spectrum disorders, diagnosis, DSM-5, standardized, interactive diagnostic tests, ADOS-2, STAT

About this article
Title

Standardized, interactive tests to diagnose autism spectrum disorder (ASD) and new diagnostic criteria in DSM-5

Journal

Psychiatria (Psychiatry)

Issue

Vol 10, No 2 (2013)

Article type

Review paper

Pages

41-48

Bibliographic record

Psychiatria 2013;10(2):41-48.

Keywords

autism spectrum disorders
diagnosis
DSM-5
standardized
interactive diagnostic tests
ADOS-2
STAT

Authors

Agnieszka Rynkiewicz
Marta Kulik

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl